Which of the following are potential precautions for pharmacists should be aware of before recommending Complementary and Alternative Medicine (CAM) products?

A. Poor data available regarding the true occurrence of adverse effects: Many CAM products lack robust post-marketing surveillance, making it difficult to accurately assess the frequency or severity of potential side effects. Pharmacists must be cautious when evaluating safety. B. Patients can obtain CAM products from unregulated or unverifiable sources: CAM products are often sold online or in stores without rigorous oversight, which can result in variable potency, contamination, or mislabeling, posing a safety risk to patients. C. Lack of quality studies about the use of natural products alone for disease state management: Scientific evidence supporting the efficacy of many CAM products is limited or inconsistent, making it challenging to provide evidence-based recommendations for disease management. D. All of the above options are precautions pharmacists should consider before recommending CAM products to a patient: Pharmacists must consider safety, sourcing, and evidence limitations when advising patients on CAM therapies to ensure informed and responsible patient care.